Clinical Trial of BT02 in Patients With Advanced Solid Tumors
NCT06404905
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Advanced Solid Tumor
Interventions
DRUG:
BT02 monoclonal antibody injection
Sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences